Scalper1 News
British biotech GW Pharmaceuticals (GWPH) Tuesday reported positive safety and efficacy data from physicians treating epileptics with its drug Epidiolex, sending the stock up 13% to a new high near 87 in morning trading on the stock market today. In the efficacy group comprising 27 patients, those taking the drug showed a 44% median overall reduction in seizure frequency over 12 weeks, with 22% showing a 90% reduction and 15% having no seizures at Scalper1 News
Scalper1 News